Parkinson Disease with Dementia
📧 Sign up to get email alerts when something new happens for Parkinson Disease with Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease [Phase 2]
Phase 2 clinical trial assessing nilotinib in Parkinson's disease with and without dementia; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder [Phase 2]
Phase 2 trial evaluating a novel NMDA modulation approach for Parkinson's disease with dementia has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 [Phase 2]
Phase 2 open-label study update for ANAVEX2-73 in Parkinson's disease with dementia has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: ANAVEX2-73 Study in Parkinson's Disease Dementia [Phase 2]
Phase 2 trial results update for ANAVEX2-73 in Parkinson's disease dementia has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) [Phase 2]
Phase 2 trial of SYN120 in Parkinson's Disease Dementia has completed; results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update examining nilotinib's safety, tolerability, pharmacokinetics, and biomarkers in Parkinson's disease and Parkin…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease [Phase 3]
A multi-centre UK Phase 3 trial of donepezil in early dementia associated with Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease [EARLY_Phase 1]
An early-phase study evaluating whether tau and beta-amyloid biomarkers can predict and diagnose dementia in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems [Phase 4]
Phase 4 trial evaluating the rivastigmine transdermal patch in Parkinson's disease patients with dementia or memory/thinking problems. Resul…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's Disease [NA]
A completed clinical trial evaluated pharmacological and electrical modulation of the NMDA pathway to assess effects on cognitive flexibilit…